Akamai CTO sells 243 shares under 10b5-1 plan
Akamai Technologies Chief Technology Officer Robert Blumofe reported a small open-market sale of company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Akamai Technologies Chief Technology Officer Robert Blumofe reported a small open-market sale of company stock. He sold 243 shares of common stock at a price of $129.41 per share in a coded "S" transaction. After this sale, he directly holds 31,006 shares and also has 152.944 shares held indirectly through a 401(k) plan. The filing notes that the sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by Blumofe, indicating it was scheduled in advance rather than timed discretionarily.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 243 | $129.41 | $31K |
| Holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F2. As of June 17, 2026.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
open-market sale financial
401(k) Plan financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did AKAM Chief Technology Officer Robert Blumofe report?
Was Robert Blumofe’s AKAM stock sale made under a Rule 10b5-1 plan?
Does Robert Blumofe have indirect AKAM holdings after the reported transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.